HAKAN GOKER

Hakan Goker stands as a prominent figure in the venture capital landscape, serving as a Managing Director at M Ventures, the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany. In this pivotal role, Hakan is instrumental in identifying, evaluating, and investing in pioneering companies that are poised to revolutionize the life science, healthcare, and technology sectors. His work directly supports Merck's strategic objectives by fostering external innovation and building a robust portfolio of future-defining enterprises.

At M Ventures, Hakan Goker's investment focus is broad yet strategically aligned with Merck's core businesses. He actively seeks out disruptive technologies and business models in areas such as biopharmaceuticals, digital health solutions, advanced materials, and deep tech. This includes companies developing novel therapeutics, diagnostic tools, medical devices, and innovative platforms that enhance research and development capabilities. Hakan is particularly interested in early-stage and growth-stage companies that demonstrate strong scientific foundations, clear market potential, and visionary leadership. His keen eye for promising ventures helps M Ventures secure a competitive edge in rapidly evolving markets.

Hakan Goker's distinguished career background provides him with a unique perspective and deep industry insight. Prior to his tenure at M Ventures, he accumulated extensive experience in both corporate development and venture capital roles, equipping him with a comprehensive understanding of what it takes for startups to succeed and scale. His expertise spans deal sourcing, due diligence, portfolio management, and strategic advisory, making him a valuable partner to the entrepreneurs he supports. This rich professional journey has allowed him to cultivate a vast network within the scientific and investment communities, further enhancing M Ventures' reach and impact.

While specific public details about Hakan Goker's individual notable investments are often proprietary to M Ventures, his contributions are evident in the overall success and strategic direction of the fund's portfolio. M Ventures is known for backing companies that deliver significant scientific breakthroughs and market value, and Hakan's leadership is integral to this track record. He is committed to fostering long-term relationships with founders, providing not just capital but also strategic guidance, operational support, and access to Merck's global resources and expertise. This holistic approach ensures that portfolio companies have the best possible chance to achieve their full potential and bring their innovations to patients and consumers worldwide. Hakan Goker continues to be a driving force in shaping the future of healthcare and technology through his strategic investments at M Ventures.